Mr Joseph M Cannon, MD | |
22281 Us Hwy 72 E, Suite B And C, Athens, AL 35613 | |
(256) 233-2158 | |
(256) 230-6825 |
Full Name | Mr Joseph M Cannon |
---|---|
Gender | Male |
Speciality | Radiology - Body Imaging |
Location | 22281 Us Hwy 72 E, Athens, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164400842 | NPI | - | NPPES |
515-33320 | Other | AL | BLUE CROSS BLUE SHIELD OF AL (VIA: THE HEART CENTER) |
CA009904395 | Medicaid | AL | |
09936176 | Medicaid | AL |
Mailing Address | Practice Location Address |
---|---|
Mr Joseph M Cannon, MD 22281 Us Hwy 72 E, Suite B And C, Athens, AL 35613 Ph: (256) 233-2158 | Mr Joseph M Cannon, MD 22281 Us Hwy 72 E, Suite B And C, Athens, AL 35613 Ph: (256) 233-2158 |
News Archive
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent study published in Human Pathology by Jefferson's Kimmel Cancer Center researchers.
Bacterial infections caused by Gram-negative bacteria such as Escherichia coli are frequently resistant to two or more antibiotics (multi-drug resistant).
Researchers have developed the first global model for predicting cardiovascular disease (CVD) risk. The model—developed by Harvard T.H. Chan School of Public Health, Imperial College London, and colleagues—will be of particular help to public health professionals, clinicians, and patients in developing countries for prevention of CVD.
› Verified 8 days ago